Liên Minh Châu Âu - Tiếng Hy Lạp - EMA (European Medicines Agency)

ceva santé animale - αδρανοποιημένο εμβόλιο coxiella burnetii, στέλεχος nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Liên Minh Châu Âu - Tiếng Hy Lạp - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

Liên Minh Châu Âu - Tiếng Hy Lạp - EMA (European Medicines Agency)

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - Εμβόλια - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

vianex a.e. - pneumococcal vaccines - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 0,5mlpf.syr.(1dose) - ΕΜΒΟΛΙΑ - pneumococcal vaccines

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

vianex a.e. - meningococcal vaccines - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 10 mcg/0,5 ml(dose) - ΕΜΒΟΛΙΑ - meningoccocal vaccines

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

vianex a.e. - vaccines - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline aebe - pertussis vaccines - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - ΕΜΒΟΛΙΑ - pertussis vaccines

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline biologicals manufacturing, wavre, belgium - bacterial and viral vaccines, combined - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - ΕΜΒΟΛΙΑ - bacterial and viral vaccines, combined

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

help ΑΒΕΕ - influenza vaccines - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - (15+15+15)μg /0.5mg - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ - influenza vaccines

Hy Lạp - Tiếng Hy Lạp - Εθνικός Οργανισμός Φαρμάκων

kite ΕΛΛΑΣ ΕΠΕ - influenza vaccines - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - (15+15+15)mc/0,5ml - ΕΜΒΟΛΙΑ - influenza vaccines